Long-term OGSIVEO treatment for up to four years associated with further tumor reductions, increased objective response rate, sustained symptom improvement, and consistent safety profile
Based on these promising results, Johnson & Johnson plans to move the program into a Phase 3 trial to further investigate subcutaneous amivantamab
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
IKS Health's innovative solution orchestrates a roll out of critical operations functions into a unified and efficient connected workflow
Indegene is strengthening its Consulting Practice to help life sciences organizations address their most pressing challenges with speed, impact, and accountability
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements
The new plant will manufacture high-quality Type I borosilicate glass tubing
First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
Subscribe To Our Newsletter & Stay Updated
